Insufficient scRNA-seq data for expression of TFAP2E at single-cell level.
Insufficient scRNA-seq data for expression of TFAP2E at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 1091.29 | 2625 / 2642 | 98% | 6.46 | 690 / 705 |
uterus | 99% | 232.22 | 169 / 170 | 86% | 4.34 | 397 / 459 |
lung | 96% | 156.21 | 557 / 578 | 79% | 3.22 | 908 / 1155 |
skin | 84% | 391.26 | 1523 / 1809 | 88% | 5.36 | 414 / 472 |
prostate | 96% | 201.87 | 234 / 245 | 69% | 1.36 | 347 / 502 |
esophagus | 87% | 128.06 | 1262 / 1445 | 75% | 2.77 | 138 / 183 |
ovary | 99% | 261.50 | 178 / 180 | 57% | 1.37 | 247 / 430 |
breast | 85% | 128.15 | 390 / 459 | 66% | 1.77 | 735 / 1118 |
bladder | 76% | 83.33 | 16 / 21 | 63% | 2.16 | 319 / 504 |
intestine | 83% | 112.95 | 800 / 966 | 44% | 1.18 | 230 / 527 |
stomach | 68% | 80.36 | 244 / 359 | 51% | 1.50 | 145 / 286 |
lymph node | 0% | 0 | 0 / 0 | 100% | 4.09 | 29 / 29 |
spleen | 100% | 219.98 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.64 | 1 / 1 |
thymus | 46% | 44.81 | 299 / 653 | 51% | 1.21 | 309 / 605 |
pancreas | 17% | 14.20 | 55 / 328 | 74% | 1.85 | 131 / 178 |
adrenal gland | 41% | 42.07 | 106 / 258 | 47% | 0.90 | 107 / 230 |
adipose | 84% | 108.68 | 1008 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 2.71 | 65 / 80 |
tonsil | 0% | 0 | 0 / 0 | 80% | 3.06 | 36 / 45 |
kidney | 49% | 50.81 | 44 / 89 | 29% | 0.47 | 263 / 901 |
blood vessel | 64% | 68.31 | 849 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 61% | 65.29 | 571 / 929 | 0% | 0 | 0 / 0 |
heart | 39% | 38.43 | 336 / 861 | 0% | 0 | 0 / 0 |
liver | 2% | 1.39 | 4 / 226 | 17% | 0.50 | 69 / 406 |
muscle | 9% | 8.05 | 76 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048856 | Biological process | anatomical structure development |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | TFAP2E |
Protein name | Transcription factor AP-2-epsilon (AP2-epsilon) (Activating enhancer-binding protein 2-epsilon) |
Synonyms | |
Description | FUNCTION: Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-epsilon may play a role in the development of the CNS and in cartilage differentiation (By similarity). . |
Accessions | ENST00000373235.4 Q6VUC0 |